Hnp Capital LLC Ampio Pharmaceuticals, Inc. Transaction History

Hnp Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	BUY	$0.42 - $0.62 $195,029 - $287,900	464,356 New	464,356 $218,000
Q2 2020 Jul 06, 2020	SELL	$0.47 - $0.72 $178,587 - $273,580	-379,973 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$0.36 - $0.74 $136,790 - $281,180	379,973 New	379,973 $159,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Hnp Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Hnp Capital LLC with notifications on news.